Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 25 | 2026 | 834 | 3.560 |
Why?
|
| Heart-Assist Devices | 17 | 2026 | 999 | 2.020 |
Why?
|
| Heart Failure | 21 | 2026 | 2318 | 2.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2024 | 174 | 0.810 |
Why?
|
| Heart Defects, Congenital | 7 | 2025 | 1908 | 0.800 |
Why?
|
| Pulmonary Heart Disease | 1 | 2022 | 4 | 0.730 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2024 | 163 | 0.690 |
Why?
|
| Child | 47 | 2026 | 26383 | 0.690 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 81 | 0.680 |
Why?
|
| Hypertension, Pulmonary | 2 | 2025 | 465 | 0.670 |
Why?
|
| Cardiomyopathies | 6 | 2026 | 518 | 0.620 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 218 | 0.610 |
Why?
|
| Organ Transplantation | 1 | 2022 | 173 | 0.600 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2019 | 108 | 0.580 |
Why?
|
| Tracheostomy | 1 | 2020 | 215 | 0.550 |
Why?
|
| Retrospective Studies | 34 | 2025 | 17772 | 0.550 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 181 | 0.540 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 313 | 0.530 |
Why?
|
| Graft Rejection | 7 | 2026 | 564 | 0.510 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 255 | 0.500 |
Why?
|
| Clostridium Infections | 1 | 2019 | 248 | 0.480 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 49 | 0.480 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 109 | 0.460 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1175 | 0.450 |
Why?
|
| Stroke Volume | 2 | 2023 | 532 | 0.430 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 255 | 0.390 |
Why?
|
| Humans | 57 | 2026 | 132194 | 0.390 |
Why?
|
| Child, Preschool | 19 | 2025 | 15103 | 0.370 |
Why?
|
| Postoperative Complications | 4 | 2022 | 3134 | 0.370 |
Why?
|
| Adolescent | 21 | 2025 | 21021 | 0.350 |
Why?
|
| Heart Ventricles | 3 | 2025 | 770 | 0.300 |
Why?
|
| Infant | 14 | 2025 | 13356 | 0.290 |
Why?
|
| Female | 28 | 2026 | 71459 | 0.290 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2021 | 141 | 0.280 |
Why?
|
| Male | 26 | 2025 | 65494 | 0.280 |
Why?
|
| Hospital Mortality | 3 | 2024 | 1074 | 0.260 |
Why?
|
| Isoantibodies | 1 | 2026 | 62 | 0.230 |
Why?
|
| Shock, Cardiogenic | 2 | 2024 | 174 | 0.230 |
Why?
|
| Glutathione Transferase | 1 | 2026 | 147 | 0.220 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2026 | 70 | 0.220 |
Why?
|
| Methylprednisolone | 1 | 2025 | 97 | 0.220 |
Why?
|
| HLA Antigens | 1 | 2026 | 226 | 0.210 |
Why?
|
| Treatment Outcome | 11 | 2025 | 13022 | 0.210 |
Why?
|
| Young Adult | 9 | 2026 | 10131 | 0.210 |
Why?
|
| Tetralogy of Fallot | 3 | 2015 | 177 | 0.190 |
Why?
|
| Allografts | 1 | 2024 | 216 | 0.190 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 45 | 0.190 |
Why?
|
| Registries | 3 | 2025 | 1602 | 0.190 |
Why?
|
| Myocarditis | 1 | 2024 | 132 | 0.190 |
Why?
|
| Echocardiography | 3 | 2025 | 1140 | 0.190 |
Why?
|
| Transplants | 1 | 2022 | 38 | 0.190 |
Why?
|
| Hemorrhage | 2 | 2023 | 506 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 304 | 0.190 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8615 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2024 | 5127 | 0.180 |
Why?
|
| Warfarin | 1 | 2023 | 123 | 0.180 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2024 | 273 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 365 | 0.180 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.180 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 5284 | 0.170 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 34 | 0.170 |
Why?
|
| Hemolysis | 1 | 2021 | 87 | 0.170 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 666 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2021 | 232 | 0.170 |
Why?
|
| Prognosis | 6 | 2024 | 4965 | 0.170 |
Why?
|
| Patient Selection | 1 | 2024 | 727 | 0.160 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2020 | 45 | 0.160 |
Why?
|
| Heart Rate | 1 | 2023 | 580 | 0.160 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 204 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 259 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 174 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2025 | 776 | 0.160 |
Why?
|
| Macrophages | 1 | 2024 | 664 | 0.150 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 139 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 215 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 217 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2022 | 237 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 627 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 379 | 0.140 |
Why?
|
| Transposition of Great Vessels | 1 | 2020 | 127 | 0.140 |
Why?
|
| Ventricular Function, Right | 2 | 2025 | 126 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1141 | 0.140 |
Why?
|
| Risk Factors | 6 | 2024 | 11041 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2023 | 505 | 0.140 |
Why?
|
| Capillaries | 1 | 2018 | 67 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 255 | 0.130 |
Why?
|
| Transplant Recipients | 3 | 2026 | 232 | 0.130 |
Why?
|
| Thrombosis | 1 | 2022 | 497 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2022 | 1240 | 0.130 |
Why?
|
| Heart | 2 | 2022 | 676 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1503 | 0.130 |
Why?
|
| Length of Stay | 2 | 2020 | 1404 | 0.130 |
Why?
|
| Cardiac Catheterization | 4 | 2025 | 637 | 0.130 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 135 | 0.130 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 343 | 0.130 |
Why?
|
| Lung Transplantation | 1 | 2021 | 357 | 0.130 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2020 | 276 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1140 | 0.120 |
Why?
|
| Graft Survival | 3 | 2024 | 466 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 424 | 0.120 |
Why?
|
| Adult | 11 | 2025 | 31771 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2016 | 60 | 0.120 |
Why?
|
| Recurrence | 1 | 2019 | 1484 | 0.120 |
Why?
|
| Myocardium | 3 | 2025 | 875 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 1052 | 0.110 |
Why?
|
| Hemodynamics | 3 | 2025 | 819 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 2869 | 0.110 |
Why?
|
| Diastole | 1 | 2015 | 179 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 690 | 0.110 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 167 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 80 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2018 | 284 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2024 | 3939 | 0.100 |
Why?
|
| Cardiac Volume | 1 | 2013 | 18 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2015 | 191 | 0.100 |
Why?
|
| Prevalence | 1 | 2020 | 2706 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2015 | 494 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2013 | 39 | 0.100 |
Why?
|
| Contrast Media | 1 | 2016 | 493 | 0.090 |
Why?
|
| United States | 3 | 2024 | 11867 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1811 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1133 | 0.090 |
Why?
|
| Survival Rate | 3 | 2025 | 2154 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 28 | 0.090 |
Why?
|
| Waiting Lists | 2 | 2024 | 243 | 0.090 |
Why?
|
| Disease Progression | 1 | 2016 | 2230 | 0.080 |
Why?
|
| Hospitalization | 3 | 2024 | 1943 | 0.070 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 542 | 0.070 |
Why?
|
| Anticoagulants | 2 | 2023 | 602 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 977 | 0.060 |
Why?
|
| Obesity | 2 | 2021 | 2395 | 0.060 |
Why?
|
| HLA-DQ Antigens | 1 | 2026 | 22 | 0.060 |
Why?
|
| Heart-Lung Transplantation | 1 | 2024 | 16 | 0.050 |
Why?
|
| Gadolinium | 1 | 2024 | 112 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1175 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 2325 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 373 | 0.050 |
Why?
|
| Time Factors | 2 | 2025 | 6289 | 0.050 |
Why?
|
| Cicatrix | 1 | 2024 | 127 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 48 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2023 | 46 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 28 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 209 | 0.050 |
Why?
|
| Chlorides | 1 | 2022 | 99 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 84 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 38 | 0.050 |
Why?
|
| Sarcomeres | 1 | 2022 | 33 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 461 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 49 | 0.050 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 50 | 0.050 |
Why?
|
| Body Mass Index | 2 | 2021 | 1697 | 0.040 |
Why?
|
| Transferrin | 1 | 2021 | 46 | 0.040 |
Why?
|
| Diuretics | 1 | 2022 | 158 | 0.040 |
Why?
|
| Antibodies | 1 | 2022 | 323 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 344 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2021 | 102 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 71 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 279 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 226 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 206 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 279 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1154 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 403 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 798 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 86 | 0.040 |
Why?
|
| Benchmarking | 1 | 2020 | 138 | 0.040 |
Why?
|
| Genotype | 1 | 2026 | 2656 | 0.040 |
Why?
|
| Biopsy | 1 | 2023 | 1254 | 0.040 |
Why?
|
| Miniaturization | 1 | 2019 | 26 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2019 | 3461 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 404 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1320 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 483 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1851 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 308 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 696 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 462 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 504 | 0.030 |
Why?
|
| Sternotomy | 1 | 2018 | 42 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 683 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 214 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 512 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 614 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 814 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 34 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 42 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3721 | 0.030 |
Why?
|
| Aorta | 1 | 2018 | 530 | 0.030 |
Why?
|
| Biomarkers | 1 | 2024 | 3429 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 776 | 0.030 |
Why?
|
| Animals | 2 | 2025 | 34291 | 0.020 |
Why?
|
| Pulmonary Circulation | 1 | 2013 | 114 | 0.020 |
Why?
|
| Exercise Test | 1 | 2011 | 243 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 2117 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 979 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1407 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 18399 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1690 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 28963 | 0.010 |
Why?
|